Xiao-Hui Zhang Selected Research

Residual Neoplasm

10/2022	Combination of KIT and FLT3-ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission.
1/2022	Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
1/2022	Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.
12/2021	A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation.
5/2021	Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
3/2021	Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
1/2021	Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission.
1/2021	Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.
1/2021	Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
1/2020	Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Hui Zhang Research Topics

Disease

48	Leukemia 10/2022 - 02/2003
46	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 04/2006
35	Residual Neoplasm 10/2022 - 07/2012
30	Infections 01/2022 - 02/2008
29	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 06/2012
21	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 05/2012
17	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2009
16	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2014
16	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 12/2016
16	Neoplasms (Cancer) 01/2021 - 02/2013
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 10/2015
10	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 04/2011
8	Bronchiolitis Obliterans Syndrome 01/2022 - 05/2013
8	Hemorrhage 01/2022 - 01/2013
8	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
7	Hematologic Diseases (Blood Diseases) 01/2022 - 12/2009
7	Philadelphia Chromosome 11/2021 - 04/2015
5	Viremia 06/2021 - 06/2009
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 11/2010
4	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2009
4	Thrombotic Microangiopathies 01/2022 - 04/2006
4	Pneumonia (Pneumonitis) 10/2021 - 06/2009
4	Inflammation (Inflammations) 05/2020 - 01/2012
4	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2012
3	Virus Diseases (Viral Diseases) 11/2022 - 05/2020
3	Fibrosis (Cirrhosis) 01/2022 - 08/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 10/2016
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Syphilis 01/2021 - 10/2015
3	Hypoxia (Hypoxemia) 01/2020 - 10/2015
3	Wilms Tumor (Wilm's Tumor) 11/2019 - 05/2016
2	Mycoses (Diseases, Fungus) 03/2022 - 07/2017
2	Gonorrhea 01/2022 - 12/2018
2	Pancytopenia 01/2022 - 03/2020
2	Hepatitis B 01/2022 - 09/2011
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Disease Progression 01/2021 - 01/2019
2	Tuberculosis (Tuberculoses) 01/2021 - 01/2020
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2015
2	Lymphoma (Lymphomas) 06/2020 - 04/2011
2	Melanoma (Melanoma, Malignant) 11/2019 - 08/2016
2	Cytopenia 08/2019 - 01/2018
2	Acute Promyelocytic Leukemia 01/2019 - 12/2007
2	Sepsis (Septicemia) 11/2018 - 05/2015
2	Hemorrhagic Cystitis 07/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

14	Inosine Triphosphate (ITP)IBA 01/2022 - 12/2016
13	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 04/2011
10	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 02/2008
9	AntigensIBA 11/2021 - 02/2003
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2011
7	InterferonsIBA 01/2022 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2015
6	Biological ProductsIBA 11/2022 - 08/2014
5	Prostaglandins FIBA 01/2022 - 10/2015
5	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
5	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2009
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2013
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 02/2013
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	SteroidsIBA 01/2021 - 01/2019
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 10/2017
3	Basiliximab FDA Link 01/2022 - 01/2020
3	Retinaldehyde (Retinal)IBA 07/2021 - 01/2014
3	AntibodiesIBA 11/2020 - 08/2010
3	Therapeutic UsesIBA 01/2020 - 10/2015
3	GlucocorticoidsIBA 01/2019 - 07/2012
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	Messenger RNA (mRNA)IBA 05/2018 - 04/2007
3	MicroRNAs (MicroRNA)IBA 05/2018 - 10/2016
2	erucylphosphocholineIBA 10/2022 - 01/2018
2	Thrombopoietin (c-mpl Ligand)IBA 01/2022 - 01/2019
2	Nucleic AcidsIBA 01/2022 - 12/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 10/2018
2	BilirubinIBA 01/2022 - 12/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 11/2021 - 12/2020
2	Pharmaceutical PreparationsIBA 10/2020 - 03/2016
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 08/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2019
2	ZincIBA 01/2020 - 01/2002
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 01/2019
2	LigandsIBA 12/2019 - 01/2017
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 08/2018

Therapy/Procedure

124	Hematopoietic Stem Cell Transplantation 10/2022 - 02/2008
47	Transplantation 01/2022 - 04/2006
35	Stem Cell Transplantation 03/2022 - 06/2012
35	Therapeutics 01/2022 - 02/2003
20	Drug Therapy (Chemotherapy) 10/2022 - 02/2008
9	Haploidentical Transplantation 01/2021 - 01/2016
5	Immunotherapy 05/2021 - 08/2016
5	Aftercare (After-Treatment) 01/2021 - 10/2015
5	Induction Chemotherapy 01/2021 - 11/2013
4	Cell Transplantation 01/2020 - 01/2016
4	Peritoneal Dialysis 07/2016 - 01/2014
3	Consolidation Chemotherapy 03/2019 - 01/2016
2	Prenatal Care (Care, Prenatal) 01/2021 - 11/2019
2	Salvage Therapy 01/2021 - 01/2021
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 11/2020